We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Rule Aims to Reduce Ambiguity, Provide Clear Direction to Sponsors
Rule Aims to Reduce Ambiguity, Provide Clear Direction to Sponsors
November 4, 2010
The FDA’s proposed regulation, Reporting Information Regarding Falsification of Data, aims to reduce any ambiguity regarding sponsors’ requirements to report suspected false data and provide clear direction on their reporting requirements, specifically in these areas: